Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Uremic Syndrome, Atypical”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04859608
What this trial is testing

Personalized Spacing of Eculizumab Infusions Based on Therapeutic Pharmacological Monitoring (EspacECU)

Who this might be right for
Hemolytic-Uremic Syndrome, Atypical
University Hospital, Tours 40
Testing effectiveness (Phase 2)Study completedNCT01193348
What this trial is testing

An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome

Who this might be right for
Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc. 22
Post-approval studies (Phase 4)Study completedNCT02574403
What this trial is testing

Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Nantes University Hospital 58
Testing effectiveness (Phase 2)WithdrawnNCT03303313
What this trial is testing

An Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alnylam Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT04861259
What this trial is testing

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Hoffmann-La Roche 83
Large-scale testing (Phase 3)Study completedNCT02949128
What this trial is testing

Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome (aHUS)
Alexion Pharmaceuticals, Inc. 58
Testing effectiveness (Phase 2)Study completedNCT00844428
What this trial is testing

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 5
Not applicableLooking for participantsNCT05996731
What this trial is testing

Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases

Who this might be right for
Atypical Hemolytic Uremic SyndromeMembranoproliferative GlomerulonephritisAutosomal Dominant Polycystic Kidney+1 more
Mario Negri Institute for Pharmacological Research 105
Large-scale testing (Phase 3)Study completedNCT03131219
What this trial is testing

Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome (aHUS)
Alexion Pharmaceuticals, Inc. 34
Testing effectiveness (Phase 2)WithdrawnNCT03999840
What this trial is testing

Eculizumab to Cemdisiran Switch in aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Mario Negri Institute for Pharmacological Research
Testing effectiveness (Phase 2)Study completedNCT03518203
What this trial is testing

Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Thrombotic MicroangiopathiesAtypical Hemolytic Uremic SyndromeMultiple Organ Dysfunction Syndrome
Children's Hospital Medical Center, Cincinnati 23
Large-scale testing (Phase 3)Looking for participantsNCT05726916
What this trial is testing

Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome

Who this might be right for
Hypertensive Emergency-associated Hemolytic Uremic Syndrome
Assistance Publique - Hôpitaux de Paris 66
Post-approval studies (Phase 4)Looking for participantsNCT07308574
What this trial is testing

Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS

Who this might be right for
aHUSAtypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT02464891
What this trial is testing

Complement Inhibition in aHUS Dialysis Patients

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Mario Negri Institute for Pharmacological Research 6
Not applicableStudy completedNCT01755429
What this trial is testing

To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients

Who this might be right for
ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)
Alexion Pharmaceuticals, Inc. 2
Not applicableLooking for participantsNCT01522183
What this trial is testing

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

Who this might be right for
Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc. 3,000
Large-scale testing (Phase 3)Study completedNCT05876351
What this trial is testing

Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China

Who this might be right for
Atypical Hemolytic Uremic
Alexion Pharmaceuticals, Inc. 25
Not applicableStudy completedNCT05405777
What this trial is testing

A Retrospective Study to Evaluate the Clinical Outcome According to Treatment in aHUS Patients in South Korea

Who this might be right for
aHUS
Handok Inc. 97
Large-scale testing (Phase 3)Study completedNCT04889430
What this trial is testing

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 34
Not applicableStudy completedNCT04749810
What this trial is testing

Observational Study of Elizaria® in aHUS Patients

Who this might be right for
Atypical Hemolytic Uremic SyndromeaHUS
AO GENERIUM 50
Next Page